Mayne can advance damages case against Cosette over $672M merger debacle
US-based drug maker Cosette has lost its bid to stay proceedings alleging it induced the treasurer to reject its $672 million tie-up with Mayne Pharma, with a judge finding Mayne has a right to prosecute its case and would be prejudiced by the delay.
For information on rights and reprints, contact subscriptions@lawyerly.com.au